{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T10:29:34Z","timestamp":1788776974475,"version":"build-2803163510"},"reference-count":40,"publisher":"Tech Science Press","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OR"],"published-print":{"date-parts":[[2025]]},"DOI":"10.32604\/or.2025.062951","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T04:20:56Z","timestamp":1749702056000},"page":"2161-2174","source":"Crossref","is-referenced-by-count":2,"title":["Nigericin-induced apoptosis in acute myeloid leukemia via mitochondrial dysfunction and oxidative stress"],"prefix":"10.32604","volume":"33","author":[{"given":"BHAVYADHARSHINI","family":"ARUN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PRARTHANA","family":"GOPINATH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANUP","family":"JHA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NISHTHA","family":"TRIPATHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SYED G","family":"DASTAGER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SYED K","family":"HASAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"17807","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41408-021-00425-3","article-title":"Acute myeloid leukemia: current progress and future directions","volume":"11","author":"Kantarjian","year":"2021","journal-title":"Blood Cancer J"},{"key":"ref2","unstructured":"Emadi A, Law JY. Acute Myeloid Leukemia (AML). [cited 2025 May 18]. Available from: https:\/\/www.msdmanuals.com\/professional\/hematology-and-oncology\/leukemias\/acute-myeloid-leukemia-aml."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1158\/2159-8290.CD-23-1145","article-title":"Targeting acute myeloid leukemia stem cells through perturbation of mitochondrial calcium","volume":"14","author":"Sheth","year":"2024","journal-title":"Cancer Discovery"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1532857","DOI":"10.3389\/fonc.2024.1532857","article-title":"Mitochondrial abnormalities as a target of intervention in acute myeloid leukemia","volume":"14","author":"Tjahjono","year":"2025","journal-title":"Front Oncol"},{"key":"ref5","first-page":"5","article-title":"Reactive oxygen species and its role in pathogenesis and resistance to therapy in acute myeloid leukemia","volume":"7","author":"Khorashad","year":"2024","journal-title":"Cancer Drug Resist"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood-2013-04-491944","article-title":"Overproduction of NOX-derived ROS in AML promotes proliferation and is associated with defective oxidative stress signaling","volume":"122","author":"Hole","year":"2013","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","article-title":"BCL-2 Inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells","volume":"12","author":"Lagadinou","year":"2013","journal-title":"Cell Stem Cell"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1182\/blood.2020009081","article-title":"Venetoclax enhances T cell-mediated antileukemic activity by increasing ROS production","volume":"138","author":"Lee","year":"2021","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1182\/blood-2009-06-222869","volume":"115","author":"Hole","year":"2010","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ccr.2006.08.009","article-title":"Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by \u03b2-phenylethyl isothiocyanate","volume":"10","author":"Trachootham","year":"2006","journal-title":"Cancer Cell"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e2210796120","DOI":"10.1073\/pnas.2210796120","article-title":"Redox metabolism maintains the leukemogenic capacity and drug resistance of AML cells","volume":"120","author":"Huang","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.3390\/ijms22052470","article-title":"Oxidative stress and ROS-mediated signaling in leukemia: novel promising perspectives to eradicate chemoresistant cells in myeloid leukemia","volume":"22","author":"Trombetti","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41419-020-2488-y","article-title":"Oxidative resistance of leukemic stem cells and oxidative damage to hematopoietic stem cells under pro-oxidative therapy","volume":"11","author":"Chen","year":"2020","journal-title":"Cell Death Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/s41591-018-0233-1","article-title":"Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia","volume":"24","author":"Pollyea","year":"2018","journal-title":"Nature Medicine"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1158\/2159-8290.CD-19-0710","article-title":"Monocytic subclones confer resistance to venetoclax-based therapy in patients with acute myeloid leukemia","volume":"10","author":"Pei","year":"2020","journal-title":"Cancer Discov"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","article-title":"Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism","volume":"7","author":"Farge","year":"2017","journal-title":"Cancer Discov"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1182\/blood-2010-05-285387","article-title":"Shortcomings in the clinical evaluation of new drugs: acute myeloid leukemia as paradigm","volume":"116","author":"Walter","year":"2010","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40170-021-00253-w","article-title":"Mitochondrial metabolism as a target for acute myeloid leukemia treatment","volume":"9","author":"Panina","year":"2021","journal-title":"Cancer Metab"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1158\/2159-8290.CD-19-1011","article-title":"Advances in the treatment of acute myeloid leukemia: new drugs and new challenges","volume":"10","author":"Short","year":"2020","journal-title":"Cancer Discov"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/MOH.0000000000000626","article-title":"Genetic heterogeneity and clonal evolution in acute myeloid leukemia","volume":"28","author":"Romer-Seibert","year":"2021","journal-title":"Curr Opin Hematol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.3390\/cancers12123742","article-title":"Acute myeloid leukemia stem cells: the challenges of phenotypic heterogeneity","volume":"12","author":"Arnone","year":"2020","journal-title":"Cancers"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"111262","DOI":"10.1016\/j.biopha.2021.111262","article-title":"Evidence of nigericin as a potential therapeutic candidate for cancers: a review","volume":"137","author":"Gao","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"14251","DOI":"10.3390\/ijms232214251","article-title":"Targeting multiple homeostasis-maintaining systems by ionophore nigericin is a novel approach for senolysis","volume":"23","author":"Deryabin","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.3389\/fonc.2020.01282","article-title":"Molecular screening for Nigericin treatment in pancreatic cancer by high-throughput RNA sequencing","volume":"10","author":"Xu","year":"2020","journal-title":"Front Oncol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ccr.2011.10.028","article-title":"Power cut: inhibiting mitochondrial translation to target leukemia","volume":"20","author":"J\u00e4r\u00e5s","year":"2011","journal-title":"Cancer Cell"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2015.07.016","article-title":"An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis","volume":"162","author":"Birsoy","year":"2015","journal-title":"Cell"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.bbrc.2009.10.042","article-title":"Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells","volume":"390","author":"Fuchs","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3390\/cancers10100360","article-title":"Ionophores: potential use as anticancer drugs and chemosensitizers","volume":"10","author":"Kaushik","year":"2018","journal-title":"Cancers"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"101042831769431","DOI":"10.1177\/1010428317694310","article-title":"Nigericin decreases the viability of multidrug-resistant cancer cells and lung tumorspheres and potentiates the effects of cardiac glycosides","volume":"39","author":"Yakisich","year":"2017 Mar","journal-title":"Tumour Biol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"628329","DOI":"10.3389\/fphar.2021.628329","volume":"12","author":"Goel","year":"2021","journal-title":"Front Pharmacol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"73448","DOI":"10.18632\/oncotarget.11866","article-title":"Low-dose salinomycin induces anti-leukemic responses in AML and MLL","volume":"7","author":"Roulston","year":"2016","journal-title":"Oncotarget"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"eadl4018","DOI":"10.1126\/sciadv.adl4018","article-title":"SF3B1 mutations provide genetic vulnerability to copper ionophores in human acute myeloid leukemia","volume":"10","author":"Moison","year":"2024","journal-title":"Sci Adv"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"700","DOI":"10.3892\/ol.2021.12961","article-title":"Combination of nigericin with cisplatin enhances the inhibitory effect of cisplatin on epithelial ovarian cancer metastasis by inhibiting slug expression via the Wnt\/\u03b2-catenin signalling pathway","volume":"22","author":"Zhou","year":"2021","journal-title":"Oncol Lett"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.3390\/cancers15123221","article-title":"Nigericin boosts anti-tumor immune response via inducing pyroptosis in triple-negative breast cancer","volume":"15","author":"Wu","year":"2023","journal-title":"Cancers"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"43085","DOI":"10.1039\/D0RA05137C","article-title":"Approach to nigericin derivatives and their therapeutic potential","volume":"10","author":"Sahu","year":"2020","journal-title":"RSC Advances"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"114938","DOI":"10.1016\/j.bcp.2022.114938","article-title":"Nigericin exerts anticancer effects through inhibition of the SRC\/STAT3\/BCL-2 in osteosarcoma","volume":"198","author":"Yang","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41419-019-1851-3","article-title":"A mechanism for increased sensitivity of acute myeloid leukemia to mitotoxic drugs","volume":"10","author":"Panina","year":"2019","journal-title":"Cell Death Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/2159-8290.CD-19-0117","article-title":"Targeting mitochondrial structure sensitizes acute myeloid leukemia to venetoclax treatment","volume":"9","author":"Chen","year":"2019","journal-title":"Cancer Discov"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1182\/blood.V95.4.1427.004k48_1427_1434","article-title":"Apoptosis of leukemic cells accompanies reduction in intracellular pH after targeted inhibition of the Na+\/H+exchanger","volume":"95","author":"Rich","year":"2000","journal-title":"Blood"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1243613","DOI":"10.3389\/fphar.2023.1243613","article-title":"The mechanisms of action of mitochondrial targeting agents in cancer: inhibiting oxidative phosphorylation and inducing apoptosis","volume":"14","author":"Yang","year":"2023","journal-title":"Front Pharmacol"}],"container-title":["Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.techscience.cn\/files\/or\/2025\/TSP_OR-33-8\/OncolRes-33-08-62951\/OncolRes-33-62951.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T01:52:38Z","timestamp":1763344358000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v33n8\/63045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":40,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025]]},"published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.32604\/or.2025.062951","relation":{},"ISSN":["1555-3906"],"issn-type":[{"value":"1555-3906","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}